Sarcopenia: Why Muscle Loss After 40 Doubles the Risk of Death

Muscle mass is not merely an aesthetic metric. Skeletal muscle accounts for approximately 40% of body weight, regulates carbohydrate metabolism, participates in immune response, and directly determines functional independence in older age. Sarcopenia — the progressive loss of muscle mass, strength, and function — has been recognized as a systemic disease with its own ICD-10 code (M62.84) since 2016 and is officially included in ICD-11.

What Is Sarcopenia and How Is It Diagnosed?

The current definition was adopted by the European Working Group on Sarcopenia in Older People (EWGSOP2). According to the consensus by Cruz-Jentoft et al., published in the journal Age and Ageing (2019), the diagnosis requires two criteria: (1) reduced muscle strength — the primary screening indicator; (2) reduced muscle mass or physical performance — the confirmatory criterion. Severe sarcopenia is defined when all three components are present: reduced strength, mass, and function.

Practical screening is straightforward: handgrip strength (dynamometry) below 27 kg in men and 16 kg in women, or inability to complete the five-times sit-to-stand test within 15 seconds — these are the thresholds used as a first diagnostic step. Muscle mass is measured by DEXA or bioimpedance analysis.

How Prevalent Is Sarcopenia?

A systematic review and meta-analysis by Wang et al. (journal Gerontology, published December 2025, data through February 2026) pooled 52 studies involving 70,202 community-dwelling older adults. The pooled prevalence of sarcopenia was 18.8% (95% CI: 15.6–22.4%). Variability across studies was substantial — from 5.2% to 50% — depending on diagnostic criteria, region, and sample age. The highest prevalence was observed using EWGSOP 2018 criteria — 25.8%.

After age 50, muscle mass declines by approximately 1% per year, while strength loss outpaces mass loss at roughly 2.5–3% per year. Population studies indicate that total muscle mass loss is approximately 6% per decade starting at age 45. After age 60, the rate of loss accelerates — especially with low physical activity, inadequate protein intake, and chronic disease.

How Is Sarcopenia Associated With Mortality Risk?

A systematic review and meta-analysis by Zhao et al. (Frontiers in Nutrition, January 2026) included 39 studies (34 prospective and 5 retrospective cohorts) with 76,151 participants — community-dwelling older adults. Key results from 29 publications (48,939 participants) for the outcome "all-cause mortality":

• Baseline sarcopenia is associated with OR = 1.79 (95% CI: 1.55–2.06) — meaning the risk of death in people with sarcopenia is almost 80% higher.
• When measured by DEXA (16 studies): OR = 1.89 (95% CI: 1.55–2.30).
• When measured by bioimpedance analysis (8 studies): OR = 1.96 (95% CI: 1.51–2.53).

Risk of functional decline in people with sarcopenia: OR = 1.90 (95% CI: 1.55–2.32) — this includes falls, loss of ability to move independently, and loss of autonomy. Associations are robust across different muscle mass measurement methods and sample characteristics, which increases confidence in the pattern.

Can Age-Related Muscle Loss Be Stopped?

Muscle loss is not a fully determined process. Key evidence-based interventions:

Progressive Resistance Training

Resistance training is the only intervention for which reliable gains in muscle mass and strength have been documented in adults over 60 in numerous RCTs. Recommended protocol: 2–3 sessions per week, load at 70–80% of one-repetition maximum (or — when restricted — slow tempo with moderate weight), key exercises targeting major muscle groups (legs, back, chest). Even 12-week programs produce measurable changes in adults aged 65–85.

Adequate Protein Intake

The PROT-AGE expert consensus (Bauer et al.) and ESPEN recommendations for older adults suggest a target range of 1.2–2.0 g of protein per kg body weight per day — substantially higher than the standard WHO recommendation of 0.8 g/kg, designed to maintain nitrogen balance in young adults. Muscle protein synthesis with age requires greater stimulation: this phenomenon is called "anabolic resistance." Distributing protein across meals (25–40 g per meal, rather than a single large dose) matters for maximizing muscle protein synthesis.

Combining Exercise and Nutrition

Combining resistance training with adequate protein produces a synergistic effect. Meta-analyses show that dietary intervention alone without training yields significantly smaller gains in muscle mass than their combination. Additionally: data on creatine monohydrate in older adults confirm its ability to enhance muscle mass gains with resistance training — this is one of the few nutrients with a robust evidence base in this context.